Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study)
Authors:
- Denise Hj DelahaijeDDDenise Hj Delahaije
- Sander Mj van KuijkSKSander Mj van Kuijk
- Carmen D DirksenCDCarmen D Dirksen
- Simone Js SepSSSimone Js Sep
- Louis L PeetersLPLouis L Peeters
- Marc E SpaandermanMSMarc E Spaanderman
- Hein W BruinseHBHein W Bruinse
- Laura D de Wit-ZuurendonkLWLaura D de Wit-Zuurendonk
- Joris Am van der PostJPJoris Am van der Post
- Johannes J DuvekotJDJohannes J Duvekot
- Jim van EyckJEJim van Eyck
- Mariëlle G van PampusMPMariëlle G van Pampus
Open Access
- 11 October 2010
- journal article
- research article
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 10 (1) , 60
Abstract
Preeclampsia and HELLP syndrome may have serious consequences for both mother and fetus. Women who have suffered from preeclampsia or the HELLP syndrome, have an increased risk of developing preeclampsia in a subsequent pregnancy. However, most women will develop no or only minor complications. In this study, we intend to determine cost-effectiveness of recurrence risk guided care versus care as usual in pregnant women with a history of early-onset preeclampsia.Keywords
This publication has 26 references indexed in Scilit:
- Prediction Tests for Recurrent Hypertensive Disease in Pregnancy, A Systematic ReviewHypertension in Pregnancy, 2009
- Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trialThe Lancet, 2009
- The HELLP syndrome: Clinical issues and management. A ReviewBMC Pregnancy and Childbirth, 2009
- Infant Growth and Stroke in Adult LifeStroke, 2007
- Pre-eclampsiaThe Lancet, 2005
- The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Hypertension in Pregnancy, 2001
- Modelling in Health Economic EvaluationPharmacoEconomics, 2000
- Construction, validation and updating of a prognostic model for kidney graft survivalStatistics in Medicine, 1995
- Growth in utero and serum cholesterol concentrations in adult life.BMJ, 1993
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990